Clinical Trial Update: A Research Study to Look at How CagriSema Influences Food Intake, Appetite and Emptying of the Stomach in People With Excess Body Weight [Phase 1]

View source ↗

Summary

Phase 1 study evaluating CagriSema's effects on food intake, appetite, and gastric emptying in adults with obesity; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: COMPLETED